Westshore Wealth, LLC Bristol Myers Squibb CO Transaction History

Westshore Wealth, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $177,776 - $212,135	-3,667 Closed	0 $0
Q3 2023 Feb 15, 2024	SELL	$57.89 - $64.73 $32,013 - $35,795	-553 Reduced 13.1%	3,667 $212,000
Q2 2023 Sep 05, 2023	BUY	$63.71 - $70.74 $35,805 - $39,755	562 Added 15.36%	4,220 $269,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $9,922 - $11,254	151 Added 4.31%	3,658 $253,000
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $2,105 - $2,319	29 Added 0.83%	3,507 $270,000
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $4,672 - $5,602	76 Added 2.23%	3,478 $254,000
Q4 2021 Feb 17, 2022	SELL	$53.63 - $62.52 $16,089 - $18,756	-300 Reduced 8.1%	3,402 $212,000
Q3 2021 Nov 16, 2021	SELL	$59.17 - $69.31 $226,206 - $264,972	-3,823 Reduced 50.8%	3,702 $219,000
Q2 2021 Aug 19, 2021	BUY	$61.91 - $67.42 $51,509 - $56,093	832 Added 12.43%	7,525 $503,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $397,162 - $446,690	6,693 New	6,693 $423,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Westshore Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Westshore Wealth, LLC with notifications on news.